908 Devices Inc.

NASDAQ:MASS

Medical - Devices

Healthcare
$9.52 +2.51%

+$0.22 today

Market cap
$395.86M
Beta
0.64
P/E (TTM)
-9.0
EPS (TTM)
-$0.97
52W Low $5.03High $9.34

Volume 0.25M

Average 0.27M

MASS Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

908 Devices Inc.NASDAQ: MASS

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 36.82M shares rose 4.0% year over year, behind the +6.4% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 5.4% from the prior quarter. Over 3 fiscal years it compounded at +7.3% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +4.0% toward the trailing-twelve-month pace of +6.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
36.82M-5.4% QoQ
Last fiscal yearDec 2025
38.92M+14.2% YoY
LTMMar 2026
36.93M+6.4% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.0%——
1 year+14.2%——
3-year CAGR+7.3%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
38.92M USD
Year-over-year change
+14.2%
4-year CAGR
+8.6%

Weighted Avg Shares (Diluted) vs competitors

How MASS compares with its peers on the latest reported figures

  • MASS's LTM Mar 2026 weighted avg shares (diluted) of 36.93M shares is the lowest of the 3 companies compared; the peer median is 247.25M shares.
  • Its year-over-year change of +6.4% is the highest of 3, against a peer median of -2.7%.
  • Over three fiscal years its annual growth of +7.3% compares with a peer median of -2.1%.
MASS Competitors Peer median
Weighted Avg Shares (Diluted) for MASS and competitors
Company Period LTM YoY 3-year CAGR
AAgilent Technologies, Inc.LTM Jul 2026283.75M -1.1%-1.8%
QGENQiagen N.V.LTM Jun 2026210.75M -4.3%-2.3%
MASS908 Devices Inc.LTM Mar 202636.93M +6.4%+7.3%
Peer median (excluding MASS) 247.25M-2.7%-2.1%

Competitors are the stored peer set for MASS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue42.21M46.85M50.23M59.63M56.2M
Cost of Revenue18.97M20.83M24.91M29.71M29.4M
Gross Profit23.23M26.02M25.32M29.93M26.8M
Gross Margin55.0%55.5%50.4%50.2%47.7%
Research & Development13.07M17.53M21.9M25.5M13.8M
Selling, General & Admin32.24M43.88M0037.18M
Operating Expenses45.3M61.41M68.08M106.64M50.98M
Depreciation & Amortization925K1.61M2.38M4.68M4.47M
EBITDA(20.76M)(31.82M)(40.27M)(43.88M)(28.88M)
EBITDA Margin-49.2%-67.9%-80.2%-73.6%-51.4%
Operating Income(22.07M)(35.38M)(42.76M)(76.72M)(24.18M)
Operating Margin-52.3%-75.5%-85.1%-128.7%-43.0%
Interest Income548K2.03M6.48M4.49M4.14M
Interest Expense486K129K201K00
Other Income / Expenses(100K)1.82M6.15M4.23M(9.16M)
Income Before Tax(22.17M)(33.56M)(36.61M)(72.49M)(33.34M)
Pre-Tax Margin-52.5%-71.6%-72.9%-121.6%-59.3%
Income Tax Expense00(211K)(282K)(66K)
Net Income(22.17M)(33.56M)(36.4M)(72.21M)(36.64M)
Net Margin-52.5%-71.6%-72.5%-121.1%-65.2%
EPS (Basic)(0.79)(1.07)(1.13)(2.12)0.54
EPS (Diluted)(0.79)(1.07)(1.13)(2.12)0.54
Weighted Avg Shares27.96M31.49M32.21M34.08M36.22M
Weighted Avg Shares (Diluted)27.96M31.49M32.24M34.08M38.92M

908 Devices Inc.

NASDAQ:MASS

Intrinsic Alpha fair value

Locked

Current Price

$9.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.